The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

Mon, 14th Oct 2019 11:06

(Correcting that Shore kept Asos at Sell, having cut from Hold back in July.)

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

CREDIT SUISSE CUTS SSE TO 'NEUTRAL' ('OUTPERFORM') - TARGET 1250 PENCE

----------

SOCGEN RAISES SSE PRICE TARGET TO 1400 (1300) PENCE - 'BUY'

----------

INVESTEC CUTS MEGGITT TO 'HOLD' ('BUY') - TARGET 640 (610) PENCE

----------

GOLDMAN RAISES WPP PRICE TARGET TO 1200 (1150) PENCE - 'BUY'

----------

GOLDMAN RAISES CRH PRICE TARGET TO 34 (33) EUR - 'NEUTRAL'

----------

CFRA CUTS MONDI PRICE TARGET TO 1800 (1850) PENCE - 'BUY'

----------

JPMORGAN CUTS OCADO TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1050 (1073) PENCE

----------

RBC CUTS FRESNILLO PRICE TARGET TO 660 (770) PENCE - 'SECTOR PERFORM'

----------

JEFFERIES CUTS NMC HEALTH PRICE TARGET TO 1925 (1986) PENCE - 'UNDERPERFORM'

----------

CANTOR FITZGERALD RAISES GLAXOSMITHKLINE TO 'BUY' (HOLD) - TARGET 2000 (1450) PENCE

----------

REDBURN CUTS RECKITT BENCKISER TO 'SELL' (NEUTRAL)

----------

FTSE 250

----------

INVESTEC RAISES QINETIQ TO 'BUY' ('HOLD') - TARGET 350 (310) PENCE

----------

UBS CUTS MEDICLINIC INTERNATIONAL PRICE TARGET TO 385 (395) PENCE - 'BUY'

----------

BARCLAYS CUTS MAN GROUP PRICE TARGET TO 180 (195) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS JUPITER FUND PRICE TARGET TO 310 (350) PENCE - 'UNDERWEIGHT'

----------

MACQUARIE RAISES DRAX TO 'OUTPERFORM' ('NEUTRAL') - TARGET 350 (280) PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING TO 'HOLD' ('SELL') - TARGET 180 (190) PENCE

----------

PEEL HUNT RAISES SENIOR TO 'BUY' ('HOLD')

----------

CREDIT SUISSE RAISES PENNON GROUP PRICE TARGET TO 700 (650) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

SHORE CAPITAL KEEPS ASOS AT 'SELL' (CUT FROM 'HOLD' ON JULY 18)

----------

PANMURE RAISES PETRA DIAMONDS TO 'BUY' ('HOLD') - TARGET 1380 (2300) PENCE

----------

INVESTEC RAISES DE LA RUE TO 'BUY' ('HOLD') - TARGET 310 PENCE

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.